1. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil. Issue 7 (July 2017) Authors: Sable, Craig A.; Ivy, D. Dunbar; Beekman, Robert H.; Clayton-Jeter, Helene D.; Jenkins, Kathy J.; Mahle, William T.; Morrow, William R.; Murphy, Mary Dianne; Nelson, Robert M.; Rosenthal, Geoffrey L.; Stockbridge, Norman; Wessel, David L. Journal: Circulation Issue: Volume 10:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A proposal for scientific framework enabling specific population drug dosing recommendations. (30th July 2015) Authors: Jadhav, Pravin R.; Cook, Jack; Sinha, Vikram; Zhao, Ping; Rostami‐Hodjegan, Amin; Sahasrabudhe, Vaishali; Stockbridge, Norman; Powell, J. Robert Journal: Journal of clinical pharmacology Issue: Volume 55:Number 10(2015:Oct.) Page Start: 1073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessing Treatment Effects That Capture Disease Burden in Serious Chronic Diseases. (May 2019) Authors: Akacha, Mouna; Binkowitz, Bruce; Claggett, Brian; Hung, H. M. James; Mueller-Velten, Guenther; Stockbridge, Norman Journal: Therapeutic innovation & regulatory science Issue: Volume 53:Number 3(2019:May) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Benefit–Risk Tradeoffs in Assessment of New Drugs and Devices. Issue 20 (17th November 2020) Authors: Kaul, Sanjay; Stockbridge, Norman; Butler, Javed Journal: Circulation Issue: Volume 142:Issue 20(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Can Bias Evaluation Provide Protection Against False‐Negative Results in QT Studies Without a Positive Control Using Exposure‐Response Analysis?. (7th July 2016) Authors: Ferber, Georg; Zhou, Meijian; Dota, Corina; Garnett, Christine; Keirns, James; Malik, Marek; Stockbridge, Norman; Darpo, Borje Journal: Journal of clinical pharmacology Issue: Volume 57:Number 1(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms. (July 2015) Authors: Sabol, Mary Elizabeth; Finkle, John; Krucoff, Mitch; Stockbridge, Norman; Parkhill, Nancy; Shinagawa, Kaori; Mahaffey, Kenneth; Tcheng, James; Lenihan, Daniel; Melloni, Chiara; Todaro, Thomas; Michelson, Eric; Munley, Jiefen; Zander, Judith; Oh, Richard Journal: Therapeutic innovation & regulatory science Issue: Volume 49:Number 4(2015:Jul.) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints. (18th April 2017) Authors: Rossignol, Patrick; Agarwal, Rajiv; Canaud, Bernard; Charney, Alan; Chatellier, Gilles; Craig, Jonathan C; Cushman, William C; Gansevoort, Ronald T; Fellström, Bengt; Garza, Dahlia; Guzman, Nicolas; Holtkamp, Frank A; London, Gerard M; Massy, Ziad A; Mebazaa, Alexandre; Mol, Peter G M; Pfeffer, M... Journal: European heart journal Issue: Volume 40:Number 11(2019) Page Start: 880 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical Trials. Issue 9 (7th January 2021) Authors: Patel, Ravi B.; Ter Maaten, Jozine M.; Ferreira, João Pedro; McCausland, Finnian R.; Shah, Sanjiv J.; Rossignol, Patrick; Solomon, Scott D.; Vaduganathan, Muthiah; Packer, Milton; Thompson, Aliza; Stockbridge, Norman; Zannad, Faiez Journal: Circulation Issue: Volume 143:Issue 9(2021) Page Start: 949 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension. (22nd August 2022) Authors: Nikkho, Sylvia M.; Richter, Manuel J.; Shen, Eric; Abman, Steven H.; Antoniou, Katerina; Chung, Jonathan; Fernandes, Peter; Hassoun, Paul; Lazarus, Howard M.; Olschewski, Horst; Piccari, Lucilla; Psotka, Mitchell; Saggar, Rajan; Shlobin, Oksana A.; Stockbridge, Norman; Vitulo, Patrizio; Vizza, Ca... Journal: Pulmonary circulation Issue: Volume 12:Number 3(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil. Issue 4 (13th April 2015) Authors: Vicente, Jose; Johannesen, Lars; Mason, Jay W.; Crumb, William J.; Pueyo, Esther; Stockbridge, Norman; Strauss, David G. Journal: Journal of the American Heart Association Issue: Volume 4:Issue 4(2015:Aug.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗